Abstract: To provide a method for producing an oyster meat essence that more amply incorporates an antioxidant substance with high ORAC value as follows. A portion of an oyster meat extract more amply incorporating an antioxidant substance with high ORAC value is selected. An extraction method that allows incorporating further large amount of antioxidant substance with high ORAC value is employed. The beneficial oyster meat extract can be efficiently extracted in large amounts. Object An oyster meat is stored in an extraction container where water is accumulated. An oyster meat essence is extracted to generate an extract liquid. The extract liquid is injected to a centrifuge, and concurrently the centrifuge is rotated at a centrifugal acceleration where an antioxidant substance with high antioxidative potency and ORAC value is separated and removed from the extract liquid. The antioxidant substance with higher antioxidative potency and ORAC value is separated.
Abstract: The present invention relates to a method for isolating a fraction having anti-inflammatory or osteoarthritis-inhibiting effects by removing impurities and washing oyster shells, which are produced during a process of producing oysters, drying same, forming a powder from the oyster shells, and adding anhydrous citric acid to same for a reaction, obtaining a reaction product, and isolating a supernatant, which is obtained by centrifugally separating the reaction product, by means of ultrafiltration. By adding the anhydrous citric acid to the oyster shell chips for the reaction at a relatively low temperature, the present invention provides superior advantages, such as significantly reducing energy costs and isolating the fraction having the anti-inflammatory or osteoarthritis inhibiting effects through a simple method.
Type:
Grant
Filed:
December 17, 2012
Date of Patent:
April 10, 2018
Assignee:
Seojin Biotech Co., Ltd.
Inventors:
Hak-Ju Kim, Ji-Sook Han, Yeoun-Ju Byoun
Abstract: The present invention relates to a composition comprising an extract of a mixture of Undaria pinnatifida sporophylls and ascidian shells for treating atopic dermatitis, wherein the composition has the excellent effect of treating atopic dermatitis through the synergistic interaction of the anti-inflammatory effect of Undaria pinnatifida sporophylls and the cell regenerative effect of ascidian shells. The composition of the invention is not involved in the suppression of cytokine production. However, it is assumed that the composition has the effects of suppressing inflammation as well as regenerating skin.
Type:
Grant
Filed:
October 31, 2012
Date of Patent:
March 13, 2018
Assignee:
INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY
Inventors:
Beyong-dae Choi, Seong-hun Jeong, Shi-hyang Park, Myung-sook Kim, Soon-ok Choi
Abstract: The present invention refers to a prebiotic mixture comprising at least one plant polysaccharide fiber and at least one of Propolis and/or Olea europaea and/or Aloe vera extracts, optionally comprising also Thymus vulgaris and/or Agrimonia eupatoria extracts. Moreover, the present invention also relates to said mixture for use in the preservation and/or in the restoration of the intestinal microbiota balance.
Type:
Grant
Filed:
March 7, 2013
Date of Patent:
March 6, 2018
Assignee:
ABOCA S.P.A. SOCIETÁ AGRICOLA
Inventors:
Valentino Mercati, Valentina Mercati, Andrea Lugli, Anna Maidecchi
Abstract: Present invention relates to a use of Radix Salviae Miltiorrhizae (Danshen) or its preparations in preparation of drugs for treating disease related to hepatic fibrosis.
Type:
Grant
Filed:
January 4, 2013
Date of Patent:
February 20, 2018
Assignee:
TASLY PHARMACEUTICAL GROUP CO., LTD.
Inventors:
Yonghong Zhu, Jinfang Hu, Jie Ma, Xiuping Shen
Abstract: The present invention relates to a pharmaceutical composition, which contains a mixture of extracts of Stemonae Radix, Asparagi Tuber, Scutellariae Radix, Schisandrae Fructus, Rehmanniae Radix Preparata, Armeniacae Semen, and Moutan Cortex Radicis, for suppressing the occurrence of inflammatory bowel diseases due to cigarette smoke, a method for preventing or treating inflammatory bowel diseases, a method for suppressing the expression of inflammatory cytokines by using the composition, and to a food composition, which contains a mixture of extracts of Stemonae Radix, Asparagi Tuber, Scutellariae Radix, Schisandrae Fructus, Rehmanniae Radix Preparata, Armeniacae Semen, and Moutan Cortex Radicis, for preventing or ameliorating inflammatory bowel diseases due to cigarette smoke.
Type:
Grant
Filed:
July 3, 2013
Date of Patent:
February 20, 2018
Assignee:
University-Industry Cooperation Group of Kyung Hee University
Inventors:
Jin Ju Kim, Eun Jung Ko, Eui Jeoung Lee
Abstract: The present invention provides a composition for improving macular pigment optical density and preventing or treating age-related macular optical degeneration. The composition comprises lutein, zeaxanthin and tea extracts, wherein the weight ratio of zeaxanthin to lutein is more than or equal to 1. The composition may prevent formation of choroidal neovascularization to achieve effects on comprehensively preventing or treating age-related macular optical degeneration (AMD).
Type:
Grant
Filed:
August 8, 2013
Date of Patent:
February 13, 2018
Assignee:
Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory
Abstract: Disclosed is a topical skin composition comprising water, a first algae extract comprising Crithmum maritimum, a second algae extract comprising Ulva lactuca, and a third algae extract.
Abstract: The invention relates to pet food compositions designed to induce the animal to cease feeding upon consumption of the appropriate nutritional amount. The invention further provides methods of inducing satiety response in animals and methods of controlling the amount of food intake in animals.
Abstract: The present invention provides therapeutic compositions comprising extracts of the plant species Echinacea purpurea and Sambucus nigra and the extract(s) of at least one further plant selected from the group consisting of Hypericum perforatum, Commiphora molmol and Centella asiatica. The compositions of the invention are of particular utility in the management of inflammatory mucosal diseases of both viral and non-viral origin.
Type:
Grant
Filed:
March 12, 2014
Date of Patent:
January 2, 2018
Assignee:
Izun Pharmaceuticals Corporation
Inventors:
William Z. Levine, Aron J. Saffer, Mina Fran
Abstract: Disclosed is a combination of lipophilic extracts of Zingiber officinale and Echinacea angustifolia for the treatment of itching, peripheral pain, superficial and deep inflammatory and painful states, pain associated with muscle spasms, herpes pain, and radiodermatitis caused by oncological radiotherapy, with or without fungal or bacterial infections.
Abstract: A pomegranate pulp extract is disclosed. The pomegranate pulp extract is effective in treating women's menopausal symptoms, due to the presence of a large amount of ellagic acid. Further disclosed is a method for further improving the treating effect of the pomegranate extract on women's menopausal symptoms. The method includes increasing the content of ellagic acid in the pomegranate extract.
Abstract: An extract of Asplenium nidus L. includes pyropheophorbide a methyl ester (C34H36N4O3), pheophorbide a methyl ester (C35H36N4O5), 1-linleoyl-3-linolenoyl-glycerol (C39H66O5), 1-linleoyl-2,3-dipalmitoyl-rac-glycerol (C53H98O6) and 1,3-dipalmitoyl-sn-glycerol (C35H68O5). The extract of Asplenium nidus L. is obtained by using a method including steps of: solvent extraction, using an solvent to extract an Asplenium nidus L. sample and to obtain an extract, with a w/v ratio between the solvent and the Asplenium nidus L. sample being 50˜60 mg/ml; and column chromatography, fractionating the extract with water and ethanol as eluent to obtain several fractions including fraction a to fraction i, and further evaporating and lyophilizing fraction b, c, d or their combination to obtain an extract of Asplenium nidus L.
Type:
Grant
Filed:
March 23, 2015
Date of Patent:
November 21, 2017
Assignees:
Jin Xin Biotechnology Co., Ltd., Academia Sinica
Abstract: The present invention relates to a diet product comprising an alginate in an aqueous dissolved or swelled form at a pH value causing the alginate not to gel until after it is consumed and comes into contact gastric acid.
Abstract: The present invention relates to oriental medicine compositions marked as SEC 22 and SEC 33 for improving digestive functions and respiratory functions for improving children's underweight, low growth and depressed respiratory organ, an oriental medicine derived therefrom, and methods of preparing them. According to an example of the present invention, the oriental medicine composition containing broiled fruit of Crataegus pinnatifida, broiled root of Atractylodes japonica, dried peel of Citrus unshiu, broiled sprout of Hordeum vulgare, broiled fruit of Amomum xanthioides, root of Zingiber officinale, dried fruit of Zizyphi, and horn of Cervus elaphus.
Abstract: The present invention relates to a novel use of sesquiterpenoid compounds, the pharmaceutically acceptable salts thereof, or the extracts of Cyperus rotundus comprising same or the fractions thereof in the prevention or treatment of menopausal diseases. The sesquiterpenoid compound according to the present invention, the extracts of Cyperus rotundus comprising the same or fractions thereof exhibit excellent estrogenic activity or anti-allergic activity, and therefore they can be used for the prevention or treatment of menopausal diseases caused by a decline in estrogen level or by allergic diseases.
Type:
Grant
Filed:
October 17, 2014
Date of Patent:
October 24, 2017
Assignee:
Research & Business Foundation Sungkyunkwan University
Abstract: A composition of matter comprises a shelf stable, partially defatted supercritical CO2 fluid solvent extracted whole grain flour derived from a cracked biomass of perilla frutescens, the flour comprising minerals and 2 to 8 percent of native seed oil, 35 to 45 percent protein, and 35 to 45 percent fiber.
Type:
Grant
Filed:
June 5, 2013
Date of Patent:
September 26, 2017
Assignee:
U.S. NUTRACEUTICALS, LLC
Inventors:
John A. Minatelli, W. Stephen Hill, Rudi E. Moerck, Uy Nguyen
Abstract: The invention relates to a novel use of the Chinese herb Glycyrrhiza inflata in treatment of neurodegenerative disorders. Particularly, the invention relates to the use of ammonium glycyrrhizinate and licochalcone A in targeting polyQ-mediated spinocerebellar ataxia.